Pay in 4 interest-free payments of $7.27 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
The intestinal barrier: A fundamental role in health and disease
Das US-amerikanische pharmazeutische Unternehmen Amylin entwickelte gentechnisch Exendin-4 und brachte es unter dem Namen Exenatid 2005 als Arzneistoff zur subkutanen Injektion fr Typ-II-Diabetiker in den Handel
This high-purity compound is supplied as a lyophilised (freeze-dried) powder , ensuring stability and precision in controlled experimental environments
Both the un-reconstituted (powder) form and the mixed solution require refrigeration
Below is a comparative summary and then some focused profiles to assist in evaluating choices along dimensions of mechanism, expected results, and clinical relevance
US$ 24.48
US$ 22.04
US$ 20.73
US$ 27.56
US$ 26.30
